Acquisition Momentum EG Life Sciences is part of the Eliassen Group, following a 2021 acquisition of The Evanston Group, signaling an integrated platform that can cross-sell life sciences consulting and talent solutions to a broader client base.

Life Sciences Focus Specialization in medical device, pharmaceutical, biometrics, and diagnostics sectors with FDA regulatory and submission support suggests opportunities to offer regulatory consulting, quality systems, and submission readiness services to life sciences companies.

Scale with Partners Parent company strength plus WBENC certification can be leveraged to pursue enterprise clients seeking diverse, certified women-owned partners and scalable talent and consulting engagements.

Talent Solutions Edge Experience in agile, cloud, risk management, and managed services positions the firm to address clients’ digital transformation, product development acceleration, and compliance programs with end-to-end talent and delivery capabilities.

Growth Signals Revenue range and historical engagement volume indicate capability to win mid-market to enterprise-level projects; potential upsell opportunities in broader life sciences operations, including program management, quality/regulatory, and data analytics.